Impact Factor Of Glycomics & Lipidomics
The glycome is that the entire complement of sugars, whether free or present in additional complex molecules, of an organism. an alternate definition is that the entirety of carbohydrates during a cell. The glycome may actually be one among the foremost complex entities in nature. "Glycomics, analogous to
genomics and
proteomics, is that the systematic study of all glycan structures of a given cell type or organism" and may be a subset of glycobiology. "Carbohydrate", "glycan", "saccharide", and "sugar" are generic terms used interchangeably during this context and includes monosaccharides, oligosaccharides, polysaccharides, and derivatives of those compounds. Carbohydrates contains “hydrated carbon”, i.e. [CH2O]n. Monosaccharides are a carbohydrate that can't be hydrolyzed into an easier carbohydrate and are the building blocks of oligosaccharides and polysaccharides. Oligosaccharides are linear or branched chains of monosaccharides attached to at least one another via glycosidic linkages. the amount of monosaccharide units can vary. Polysaccharides are glycans composed of repeating monosaccharides, generally greater than ten monosaccharide units long . The glycome exceeds the complexity of the proteome as a results of the even greater diversity of the glycome's constituent carbohydrates and is further complicated by the sheer multiplicity of possibilities within the combination and interaction of the carbohydrates with one another and with proteins. "The spectrum of all glycan structures — the glycome — is immense. In humans, its size is orders of magnitude greater than the amount of proteins that are encoded by the genome, one-hundredth of which encodes proteins that make, modify, localize or bind sugar chains, which are referred to as glycans.
High Impact List of Articles
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
Relevant Topics in Clinical